Background Toxoplasma gondii infection causes toxoplasmosis, an infectious disease with
worldwide prevalence. The limited efficiency of drugs against this infection, their side effects
and the potential appearance of resistant strains make the search of novel drugs an
essential need. We examined Eurycoma longifolia root extract and fractions as potential
sources of new compounds with high activity and low toxicity. The main goal of this study
was to investigate the anti-T. gondii activity of crude extract (TACME) and four fractions (TAF …

Background: Toxoplasma gondii infection causes toxoplasmosis, an infectious disease with
worldwide prevalence. The limited efficiency of drugs against this infection, their side effects
and the potential appearance of resistant strains make the search of novel drugs an
essential need. We examined Eurycoma longifolia root extract and fractions as potential
sources of new compounds with high activity and low toxicity. The main goal of this study
was to investigate the anti-T. gondii activity of crude extract (TACME) and four fractions (TAF …